- Motley Fool•14 hours ago
Why you should keep your eyes on Amgen, Jazz, Lexicon, Regeneron, and Synergy in Q1.
- Investor's Business Daily•yesterday
Regeneron and Sanofi argue Amgen's patents covering LDL-buster Repatha are too broad.
- Zacks•2 days ago
Two important regulatory events scheduled in the first quarter of 2017.
REGN : Summary for Regeneron Pharmaceuticals, Inc. - Yahoo Finance
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||357.56 x 100|
|Ask||364.00 x 100|
|Day's Range||358.93 - 365.95|
|52 Week Range||325.35 - 484.57|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||52.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|